This ketamine trial for resistant depression shows positive results.
The study is the largest to date comparing generic ketamine with placebo in treating severe depression.
Read morePsychedelic Research, Risks and Benefits
Here a UC researcher discusses how psychedelics show promise for treating PTSD and anxiety, but risks remain.
Read moreChemical Imbalance Theory
Keep reading for the history of the chemical imbalance theory, how a study last year tried to debunk it, and how that study is now seen to be flawed.
Read morePsychological Strengths with Psychedelic Use
The findings, published in the International Journal of Wellbeing, indicate that self-transcendent experiences play a key role in predicting positive outcomes of psychedelic use.
Read moreMicrodosing and Authenticity
A recent study found that on the microdosing day and the day thereafter, state authenticity was significantly higher.
Furthermore, the number of activities and the satisfaction with them were higher on the day when participants microdosed, while the following day only the number of activities was higher.
The researchers propose that feeling and behaving authentically could have a central role in explaining the positive effects of microdosing on health and wellbeing that are reported by their study.
5-MeO-DMT Research
A first patient has been dosed in 5-MeO-DMT for a depression trial.
The trial is being carried out by Beckley Psytech.
Read morePsychedelic Research Q & A
Psychedelic Science Conference- Review
Here’s another review of the recent Psychedelic Science conference.
It sounds like a mixed bag, as the psychedelic renaissance continues to have growing pains.
Microdosing Mushrooms? Results Are Still Mixed.
Microdosing psychedelics has benefits, users say. Science isn’t convinced.
Read moreSense of Self
Researchers identified a small structure in the brain, the anterior precuneus or aPCu, as a crucial component in establishing our physical self or “I”. Keep reading and watch the video here.
Read moreMore on the Therapeutic Potential of Mushrooms
Fred Barrett, a neuroscientist at the Johns Hopkins Center for Psychedelic & Consciousness Research, discusses the revolutionary healing potential of psilocybin, what is not yet known about the compound’s role in treating various psychiatric disorders, the importance of the “therapy” aspect of psychedelic-assisted therapy, and the hurdles that remain to this treatment being accessible to the general public.
Read more